VR Logo

Agios Pharmaceuticals Inc. (AGIO) download report


Healthcare | Biotechnology & Pharma Research

Agios Pharmaceuticals Inc. (AGIO) Premium Coverage

53 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology.

IPO Date: 24-Jul-2013

CEO & Director: Dr. Jacqualyn A. Fouse Ph.D.

CFO & Head of Corp. Affairs: Mr. Jonathan Biller J.D.

Listing: NASDAQ: AGIO

Country: United States

Headquarters: Cambridge, MA

Website: https://www.agios.com

Key Facts

Market cap: $1,279.87 Mln

Revenue (TTM): $0.83 Mln

Earnings (TTM): $-364.38 Mln

Cash: $923.53 Mln

Total Debt: $94.61 Mln

Insider's Holding: 1.34%

Liquidity: Low

52 Week range: $16.75 - 58.61

Shares outstanding: 54,788,900

10 Years Aggregate:

  • CFO: $-1,768.81 Mln
  • EBITDA: $-1,772.37 Mln
  • Net Profit: $-224.04 Mln

Stock Performance

Time Period Agios Pharmaceuticals (AGIO) S&P BSE Sensex S&P Small-Cap 600
YTD-28.93-9.18-18.78
1 month17.80-4.78-8.00
3 months-19.75-9.66-13.65
1 Year-57.610.81-17.19
3 Years-22.3410.336.10
5 Years-14.6111.345.87
10 Years--11.749.84
As on 01-Jul-2022
Year Agios Pharmaceuticals (AGIO) S&P Small-Cap 600 S&P BSE Sensex
2021-24.1425.2721.99
2020-9.269.5715.75
20193.5620.8614.38
2018-19.25-9.705.87
201737.0011.7327.91
2016-35.7224.741.95
2015-42.06-3.36-5.03